Related Experiment Video

Updated: Jun 28, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Antithrombotic effects of targeting alphaIIbbeta3 signaling in platelets

Ararat J Ablooglu1, Jian Kang, Brian G Petrich

  • 1Department of Medicine, University of California San Diego, La Jolla, CA 92093-0726, USA. aablooglu@ucsd.edu

Blood
|November 14, 2008
PubMed

Insights

Deleting specific beta3 residues disrupts alphaIIbbeta3 signaling, preventing platelet spreading and protecting mice from arterial thrombosis. This suggests targeting alphaIIbbeta3 signaling is a potential antithrombotic strategy.

Area of Science:

  • Hematology
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Integrin alphaIIbbeta3 plays a crucial role in platelet aggregation and thrombosis.
  • Outside-in signaling mediated by alphaIIbbeta3, particularly its interaction with fibrinogen and c-Src, is critical for platelet function.
  • The C-terminal residues of beta3 integrin are essential for c-Src binding and downstream signaling.

Purpose of the Study:

  • To investigate the in vivo consequences of disrupted alphaIIbbeta3-c-Src interaction on platelet function and arterial thrombosis.
  • To generate and characterize a novel beta3(Delta760-762) knockin mouse model lacking key C-terminal residues for c-Src binding.
  • To evaluate the therapeutic potential of targeting alphaIIbbeta3 signaling as an antithrombotic strategy.

Main Methods:

  • Generation of beta3(Delta760-762) knockin mice lacking the arginine-glycine-threonine (RGT) motif.
  • Comparison of platelet spreading, tyrosine phosphorylation, and fibrinogen binding in wild-type, heterozygous, and knockin mice.
  • Assessment of arterial thrombosis in vivo using a ferric chloride (FeCl3) carotid artery injury model.
  • Evaluation of bleeding times and spontaneous bleeding in the generated mouse models.

Main Results:

  • Beta3(Delta760-762) platelets exhibited impaired spreading and reduced tyrosine phosphorylation of c-Src substrates compared to controls.
  • Beta3(Delta760-762) mice were significantly protected from FeCl3-induced carotid artery thrombosis.
  • While some beta3(Delta760-762) mice showed prolonged bleeding times, they did not exhibit spontaneous or excessive bleeding.
  • Fibrinogen binding was normal in response to some agonists but impaired with adenosine diphosphate stimulation.

Conclusions:

  • Deletion of the beta3 RGT motif disrupts c-Src-mediated alphaIIbbeta3 signaling, leading to impaired platelet function.
  • Disruption of this signaling pathway confers protection against arterial thrombosis in vivo.
  • Targeting alphaIIbbeta3 signaling represents a promising antithrombotic therapeutic strategy.

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader07:13

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader

Published on: May 24, 2024

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...